Atdna Therapeutics Private Limited - Company Profile

It is a research & development private limited company based in Kakinada, Andhra Pradesh, India, established in 2015.
2015 Kakinada, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Atdna Therapeutics Private Limited

Atdna Therapeutics Private Limited, a struck off private limited company, was established on 05 January 2015 in Kakinada, Andhra Pradesh, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U74900AP2015PTC095956. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Venkata Giri Babu Talluri (Director), Murali Mohan Alapati (Director). Its latest AGM occurred on 01 September 2018, with the balance sheet filed on 31 March 2018. It is based at D.No.3-18/A-4, Ayodhya Nagar, Kakinada, Andhra Pradesh, 533003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900AP2015PTC095956

  • Registration Number

    095956

  • Incorporation Date

    05 January 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 1 Month
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** %
  • Profit Growth **** 51.30%
  • Ebitda **** 82.03%
  • Net Worth -26.42%
  • Total Assets -2.35%
Company report

Atdna Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Atdna Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Atdna Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Giri Babu Talluri Director 05 Jan 2015 Current
Murali Mohan Alapati Director 05 Jan 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Atdna Therapeutics.

Atdna Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 51.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.42%.

Atdna Therapeutics revenue growth over time
Atdna Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -2.35%
*******
*******
*******
*******
Profit or Loss
*******
 51.30%
*******
*******
*******
*******
Net Worth
*******
 -26.42%
*******
*******
*******
*******
EBITDA
*******
 82.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Atdna Therapeutics?

In 2017, Atdna Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Atdna Therapeutics?

Unlock and access historical data on people associated with Atdna Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Atdna Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atdna Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Atdna Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Atdna Therapeutics Private Limited last Annual general meeting of members was held on 01 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    Atdna Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Vijayawada. was recorded as a recent event.

  • Director Appointment

    Venkata Giri Babu Talluri was appointed as a Director was appointed as a Director on 05 Jan 2015 & has been associated with this company since 11 years 1 month . was recorded as a recent event.

  • Director Appointment

    Murali Mohan Alapati was appointed as a Director was appointed as a Director on 05 Jan 2015 & has been associated with this company since 11 years 1 month . was recorded as a recent event.

  • Company Incorporation

    The activity Atdna Therapeutics Private Limited was registered on 05 Jan 2015 with Roc Vijayawada & aged 11 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Atdna Therapeutics Private Limited?

The CIN of Atdna Therapeutics Private Limited is U74900AP2015PTC095956.

Where is Atdna Therapeutics Private Limited headquartered?

Atdna Therapeutics Private Limited is headquartered at D.No.3-18/A-4, Ayodhya Nagar, Kakinada, Andhra Pradesh, 533003.

When was Atdna Therapeutics Private Limited incorporated?

Atdna Therapeutics Private Limited was incorporated on 05 January 2015.

Who are the current directors of Atdna Therapeutics Private Limited?

The current directors of Atdna Therapeutics Private Limited are

What is the primary industry of Atdna Therapeutics Private Limited?

The primary industry of Atdna Therapeutics Private Limited is Professional, Scientific And Technical.

Is Atdna Therapeutics Private Limited a listed company?

Atdna Therapeutics Private Limited is unlisted.

What is the capital structure of Atdna Therapeutics Private Limited?

The authorized capital of Atdna Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Atdna Therapeutics Private Limited?

The compliance status of Atdna Therapeutics Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available